Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
Current Opinion in HIV and AIDS|April 4, 2017
Universal antiretroviral regimens: thinking beyond one-pill-once-a-dayJeffrey M Jacobson, Charles W FlexnerTopics in HIV Medicine : a Publication of the International AIDS Society, USA|April 30, 2003
Advances in HIV pharmacology: protein binding, pharmacogenomics, and therapeutic drug monitoringCharles W FlexnerCurrent Opinion in HIV and AIDS|April 14, 2017
Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settingsGary Maartens, Marta Boffito, Charles W FlexnerAIDS Patient Care and Stds|January 7, 2003
Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?Gregory M Lucas, Charles W Flexner, Richard D MooreCurrent Opinion in HIV and AIDS|April 18, 2009
The rationale for immunosuppressive therapy for HIV infectionJeffrey M JacobsonCurrent HIV/AIDS Reports|August 11, 2005
Immune-based therapies: an adjunct to antiretroviral treatmentJeffrey M JacobsonJournal of Acquired Immune Deficiency Syndromes (1999)|July 2, 2005
The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosingDavid J Back, David M Burger, Charles W Flexner, et al.AIDS Reviews|December 15, 2018
Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are DevelopedJeffrey M Jacobson, Kamel KhaliliCurrent Opinion in HIV and AIDS|April 3, 2009
CCR5 monoclonal antibodies for HIV-1 therapyWilliam C Olson, Jeffrey M JacobsonPageof 17